SCHEMBL3870874

SCHEMBL3870874

[CH2]CCCCCCCCCCC=O

nearest known ligand 0.53

Predicted protein targets (top 5)

geneUniProtsupporting neighboursconfidence
HIF1A Q16665 1/20 0.53
TSHR P16473 2/20 0.52
FAAH O00519 2/20 0.46
TRPV1 Q8NER1 2/20 0.46
ALDH1A1 P00352 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19582101 1.00 HIF1A (0.53) HIF1ATSHRFAAHTRPV1ALDH1A1
SCHEMBL3863715 1.00 HIF1A (0.53) HIF1ATSHRFAAHTRPV1ALDH1A1
SCHEMBL5617897 1.00 HIF1A (0.53) HIF1ATSHRFAAHTRPV1ALDH1A1
SCHEMBL19582254 1.00 HIF1A (0.53) HIF1ATSHRFAAHTRPV1ALDH1A1
SCHEMBL355148 1.00
SCHEMBL19582226 1.00 HIF1A (0.53) HIF1ATSHRFAAHTRPV1ALDH1A1
SCHEMBL1407529 1.00 HIF1A (0.53) HIF1ATSHRFAAHTRPV1ALDH1A1
SCHEMBL5705911 1.00 HIF1A (0.53) HIF1ATSHRFAAHTRPV1ALDH1A1
SCHEMBL3667866 1.00 HIF1A (0.53) HIF1ATSHRFAAHTRPV1ALDH1A1
SCHEMBL3878003 1.00

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 56 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4189027-A1 CMP COMPOSITION INCLUDING ANIONIC AND CATIONIC INHIBITORS CMC Materials, Inc. (US) 2023-06-07 EP claimed
WO-2022026355-A1 CMP COMPOSITION INCLUDING ANIONIC AND CATIONIC INHIBITORS CMC MATERIALS, INC. (US) 2022-02-03 WO claimed
US-20050043182-A1 Agrochemical compositions SYNGENTA CROP PROTECTION, INC. 2005-02-24 US claimed
EP-1347681-A2 AGROCHEMICAL COMPOSITIONS Syngenta Participations AG (CH) 2003-10-01 EP claimed
WO-2002045507-A2 MICROEMULSIFIABLE AGROCHEMICAL CONCENTRATE SYNGENTA PARTICIPATIONS AG (CH) 2002-06-13 WO claimed
EP-0365539-A4 HUMAN LEUCOCYTE ELASTASE INHIBITOR COMPOUNDS 1990-12-05 EP claimed
EP-0365539-A1 HUMAN LEUCOCYTE ELASTASE INHIBITOR COMPOUNDS AUSTRALIAN COMMERCIAL RESEARCH & DEVELOPMENT LIMITED (AU) 1990-05-02 EP claimed
WO-1988010258-A1 HUMAN LEUCOCYTE ELASTASE INHIBITOR COMPOUNDS LA TROBE UNIVERSITY (AU) 1988-12-29 WO claimed
CN-107365418-B Polyallylamine derivatives 味之素株式会社 2022-04-01 CN disclosed
US-11008278-B1 Methods of making benzophenonyl(alk)acrylic esters and substituted benzophenonyl(alk)acrylic esters in flow reactors 3M INNOVATIVE PROPERTIES COMPANY (US) 2021-05-18 US disclosed
US-20210130280-A1 METHODS OF MAKING BENZOPHENONYL(ALK)ACRYLIC ESTERS AND SUBSTITUTED BENZOPHENONYL(ALK)ACRYLIC ESTERS IN FLOW REACTORS 3M INNOVATIVE PROPERTIES COMPANY 2021-05-06 US disclosed
EP-3638646-A1 METHODS OF MAKING BENZOPHENONYL(ALK)ACRYLIC ESTERS AND SUBSTITUTED BENZOPHENONYL(ALK)ACRYLIC ESTERS IN FLOW REACTORS 3M Innovative Properties Company (US) 2020-04-22 EP disclosed
CN-110709377-A Process for preparing dibenzoyl (alkyl) acrylates and substituted dibenzoyl (alkyl) acrylates in a flow reactor 3M创新有限公司 2020-01-17 CN disclosed
US-10280267-B2 Polyallylamine derivative AJINOMOTO CO., INC. (JP) 2019-05-07 US disclosed
EP-0227531-A2 Pyroglutamic acid esters used as dermal penetration enhancers for drugs MERCK & CO. INC. (US) 1987-07-01 EP disclosed
US-4477615-A Polypiperidinyl stabilizing agents for polymer materials APITAL PRODUZIONI INDUSTRIALI S.P.A. (IT) 1984-10-16 US disclosed
EP-0023330-B1 2,2,6,6-TETRAALKYL-4-PIPERIDYL ALCOHOL ESTERS OF TETRADECYLENE POLYCARBOXYLIC ACIDS AS LIGHT STABILIZERS FOR SYNTHETIC POLYMERS AND STABILIZED COMPOSITIONS ADEKA ARGUS CHEMICAL CO., Ltd. (JP) 1983-04-13 EP disclosed
US-4351962-A Process for the preparation of hydroxy benzene carboxaldehydes RHONE POULENC INC. (US) 1982-09-28 US disclosed
US-4312804-A HEAT RESISTANCE, ULTRAVIOLET RADIATION RESISTANCE ARGUS CHEMICAL CORPORATION (US) 1982-01-26 US disclosed
EP-0023330-A1 2,2,6,6-Tetraalkyl-4-piperidyl alcohol esters of tetradecylene polycarboxylic acids as light stabilizers for synthetic polymers and stabilized compositions ADEKA ARGUS CHEMICAL CO., Ltd. (JP) 1981-02-04 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11008278-B1 Methods of making benzophenonyl(alk)acrylic esters and substituted benzophenonyl(alk)acrylic esters in flow reactors ALK, ADH1C, ADH5 HIF1A 2243/4885TSHR 2969/4885FAAH 60/4885
US-20210130280-A1 METHODS OF MAKING BENZOPHENONYL(ALK)ACRYLIC ESTERS AND SUBSTITUTED BENZOPHENONYL(ALK)ACRYLIC ESTERS IN FLOW REACTORS ALK, ADH1C, ADH5 HIF1A 2243/4885TSHR 2969/4885FAAH 60/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.